Related Experiment Videos
New treatment modalities for end-stage emphysema.
Thomas M T Hwong1, Anthony P C Yim
1Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, SAR, China.
Chest Surgery Clinics of North America
|December 20, 2003
Summary
Nonresectional lung volume reduction surgery (LVRS) shows promise for emphysema patients. Further research is needed to determine optimal patient selection and refine techniques for better outcomes.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Medical Device Technology
Background:
- Lung volume reduction surgery (LVRS) is an evolving treatment for severe emphysema.
- Nonresectional approaches to LVRS are being developed as alternatives to traditional resection.
- Current investigations into nonresectional LVRS are preliminary, with many questions remaining.
Purpose of the Study:
- To evaluate the potential of nonresectional LVRS as a therapeutic strategy.
- To identify challenges and areas for future development in nonresectional LVRS devices and techniques.
- To explore methods for optimizing patient selection for nonresectional LVRS procedures.
Main Methods:
- Review of existing studies on nonresectional LVRS strategies.
- Discussion of current device designs and their ongoing evolution.
- Consideration of patient selection criteria, including the role of radioactive isotope scans for collateral flow assessment.
Main Results:
- Preliminary data for nonresectional LVRS are encouraging.
- Patient selection remains critical for achieving successful outcomes.
- Further studies are needed to assess efficacy in homogenous emphysema and to refine patient selection tools.
Conclusions:
- Nonresectional LVRS is a promising concept with ongoing technological advancements.
- Further research, including larger studies with long-term follow-up, is warranted.
- Refining patient selection, particularly identifying those unlikely to benefit, is crucial for future success.